← Back to Search

Treatment for Alzheimer's Disease (DIAN Trial)

N/A

Recruiting

Led By Randall J. Bateman, MD

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

This trial is looking for possible biomarkers of Alzheimer's in people with a genetic predisposition for the disease.

Eligible Conditions

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Do I qualify?Apply below to find out

Washington University School of MedicineLead Sponsor

1,970 Previous Clinical Trials

2,307,923 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,733 Previous Clinical Trials

28,054,303 Total Patients Enrolled

Alisha Daniels, MD,MHAStudy Director(314) 273-9057

~32 spots leftby Jul 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.